Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial

Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial

There is critical need for a clinically useful tool to predict antidepressant treatment outcome in major depressive disorder (MDD) to reduce suffering and mortality. This analysis sought to build upon previously reported antidepressant treatment efficacy prediction from 2-[18F]-fluorodeoxyglucose -...

Full description

Bibliographic Details
Main Authors: Kathryn R. Hill, John D. Gardus, Elizabeth A. Bartlett, Greg Perlman, Ramin V. Parsey, Christine DeLorenzo
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:NeuroImage: Clinical
Subjects:
Major depressive disorder
Treatment response
FDG-PET
Prediction of response
Dynamic imaging
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158221003028

Internet

http://www.sciencedirect.com/science/article/pii/S2213158221003028

Similar Items